Yen‐Hao Su

1.4k total citations
54 papers, 1.1k citations indexed

About

Yen‐Hao Su is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yen‐Hao Su has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Oncology. Recurrent topics in Yen‐Hao Su's work include MicroRNA in disease regulation (12 papers), Bariatric Surgery and Outcomes (10 papers) and Cancer-related molecular mechanisms research (6 papers). Yen‐Hao Su is often cited by papers focused on MicroRNA in disease regulation (12 papers), Bariatric Surgery and Outcomes (10 papers) and Cancer-related molecular mechanisms research (6 papers). Yen‐Hao Su collaborates with scholars based in Taiwan, China and United States. Yen‐Hao Su's co-authors include Yun Chen, Po‐Huang Lee, Jin‐Tung Liang, Sheng-Hong Tseng, Hong‐Shiee Lai, Hsin‐Yi Huang, Ming‐Chih Ho, Ming-Shian Tsai, Wei‐Jei Lee and Jung‐Chien Chen and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Yen‐Hao Su

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yen‐Hao Su Taiwan	17	474	290	274	266	195	54	1.1k
Weiping Yang China	22	626 1.3×	301 1.0×	265 1.0×	446 1.7×	190 1.0×	68	1.4k
Jing Liang China	18	295 0.6×	258 0.9×	181 0.7×	107 0.4×	127 0.7×	73	1.0k
Qun Zhao China	21	493 1.0×	364 1.3×	282 1.0×	352 1.3×	451 2.3×	133	1.3k
Hua Xiao China	22	508 1.1×	356 1.2×	364 1.3×	276 1.0×	309 1.6×	91	1.3k
Haidong Yan China	20	657 1.4×	152 0.5×	174 0.6×	66 0.2×	175 0.9×	29	1.5k
Ruimin Sun China	15	790 1.7×	87 0.3×	93 0.3×	498 1.9×	520 2.7×	33	1.3k
Hideya Kashihara Japan	19	265 0.6×	515 1.8×	498 1.8×	121 0.5×	462 2.4×	132	1.3k
Cheng Liu China	21	536 1.1×	601 2.1×	182 0.7×	242 0.9×	234 1.2×	82	1.5k
Ponnandai Somasundar United States	19	238 0.5×	542 1.9×	527 1.9×	287 1.1×	264 1.4×	77	1.8k
Kyle J. Thompson United States	19	266 0.6×	156 0.5×	323 1.2×	147 0.6×	116 0.6×	60	998

Countries citing papers authored by Yen‐Hao Su

Since Specialization

Citations

This map shows the geographic impact of Yen‐Hao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Hao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Hao Su more than expected).

Fields of papers citing papers by Yen‐Hao Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Hao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Hao Su. The network helps show where Yen‐Hao Su may publish in the future.

Co-authorship network of co-authors of Yen‐Hao Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Hao Su. A scholar is included among the top collaborators of Yen‐Hao Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Hao Su. Yen‐Hao Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wanyu, Hsin‐An Chen, Chih-Ming Su, et al.. (2025). FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma. Cancer & Metabolism. 13(1). 7–7. 1 indexed citations

Liu, Shing‐Hwa, et al.. (2024). Imperatorin ameliorates ferroptotic cell death, inflammation, and renal fibrosis in a unilateral ureteral obstruction mouse model. Phytomedicine. 135. 156066–156066. 4 indexed citations

Park, Ji Min, Yen‐Hao Su, Hsin‐Hua Chen, et al.. (2024). Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells. Experimental & Molecular Medicine. 56(9). 2065–2081. 4 indexed citations

Chen, Ching‐Yi, Wen‐Jeng Lee, Kazunori Kasama, et al.. (2024). Mid- and long-term renal outcomes after metabolic surgery in a multi-center, multi-ethnic Asian cohort with T2DM. Clinical Kidney Journal. 17(10). sfae260–sfae260. 1 indexed citations

Su, Yen‐Hao, et al.. (2023). Prediction of 5-Year Weight Loss and Weight Regain According to Early Weight Loss after Sleeve Gastrectomy. Obesity Surgery. 33(5). 1366–1372. 3 indexed citations

Bianco, John, Marc Derieppe, Yen‐Hao Su, et al.. (2023). Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model. Journal of Controlled Release. 357. 287–298. 13 indexed citations

Yeh, Yu‐Wen, Yen‐Hao Su, Chih‐Hsin Wang, et al.. (2023). Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression. Aging. 15(22). 12873–12889.

Park, Ji Min, Jei‐Ming Peng, Yen‐Hao Su, et al.. (2022). Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer. Molecular Metabolism. 65. 101576–101576. 7 indexed citations

Chiu, Ching‐Feng, Ji Min Park, Hsin‐Hua Chen, et al.. (2022). Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma. Biomedicine & Pharmacotherapy. 153. 113520–113520. 6 indexed citations

10.

Yang, Po‐Jen, Yen‐Hao Su, Po‐Chu Lee, et al.. (2021). Predictors of diabetes relapse after metabolic surgery in Asia. Surgery for Obesity and Related Diseases. 18(4). 454–461. 2 indexed citations

11.

Loh, El‐Wui, et al.. (2020). Efficacy of Fibrin Sealant in Reducing Complication Risk After Bariatric Surgery: a Systematic Review and Meta-analysis. Obesity Surgery. 31(3). 1158–1167. 10 indexed citations

12.

Su, Yen‐Hao, Wanchun Tang, Ya‐Wen Cheng, et al.. (2015). Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(10). 2261–2272. 52 indexed citations

13.

Cherng, Yih‐Giun, et al.. (2015). Postoperative recovery after anesthesia in morbidly obese patients: a systematic review and meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 62(8). 907–917. 37 indexed citations

14.

Su, Yen‐Hao, et al.. (2014). Suppression of Dicer Increases Sensitivity to Gefitinib in Human Lung Cancer Cells. Annals of Surgical Oncology. 21(S4). 555–563. 24 indexed citations

15.

Chen, Pisin, Yi‐Hua Jan, Michael Hsiao, et al.. (2012). MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene. 32(4). 431–443. 111 indexed citations

16.

Ser, Kong-Han, Wei‐Jei Lee, Yi-Chih Lee, et al.. (2010). Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surgical Endoscopy. 24(9). 2253–2259. 90 indexed citations

17.

Su, Yen‐Hao, et al.. (2009). Patient factors predicting the completion of sedation-free colonoscopy.. PubMed. 55(86-87). 1606–8. 13 indexed citations

18.

Su, Yen‐Hao, et al.. (2005). Lung Cancer Metastasis to the Filum Terminale-Case Report. Tzu Chi Medical Journal. 17(6). 421–423.

19.

Chen, Yun, et al.. (2005). Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats. Cancer Immunology Immunotherapy. 55(7). 873–883. 8 indexed citations

20.

Gao, Pan, Yen‐Hao Su, & Yan Gao. (1994). [A murine model of mammary adenocarcinoma (VI TA2MA-891) with high rate of spontaneous metastases in the lungs].. PubMed. 16(2). 147–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact